ICD-10-CM Billable Code

H80.93

Unspecified otosclerosis, bilateral

Clinical Classification Guidelines

Medical Intelligence & Overview

Unspecified bilateral otosclerosis is a condition that affects the bones in the middle ear, leading to hearing loss in both ears. Otosclerosis involves abnormal bone growth around the stapes bone, one of the tiny bones in the middle ear that helps transmit sound vibrations to the inner ear. When this condition is diagnosed as unspecified, it indicates that the specific details of the otosclerosis have not been classified further. Being bilateral means that both ears are affected, which can impact hearing abilities significantly.

Causes & Symptoms

Clinical Causes: Genetic predisposition, often running in families Hormonal factors, especially during pregnancy Viral infections that affect bone growth Environmental factors like exposure to toxins or loud noise

Key Symptoms: Gradual hearing loss in both ears Tinnitus (ringing or buzzing in the ears) Musical sounds like clicking or crackling heard during movement Dizziness or balance problems in some cases Difficulty understanding speech, especially in noisy environments

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of hearing tests and physical examinations. A healthcare provider may perform audiometry to assess hearing ability and use imaging studies such as CT scans to examine the bones of the middle ear. The diagnosis of unspecified otosclerosis indicates that specific subtypes or detailed classifications are not determined, but signs of abnormal bone growth around the stapes are evident. Medical history, family history, and symptom progression are also considered during evaluation.

Treatment Protocols: Treatment options aim to improve hearing and manage symptoms. Common approaches include: - Surgical procedures like stapedectomy or stapedotomy, where the affected bone is replaced or bypassed to restore hearing - Hearing aids to amplify sound and assist with hearing difficulties - Medical management may include certain medications, although their effectiveness is limited - Regular monitoring and audiological assessments to track progression An individualized treatment plan is developed based on the severity of hearing loss and patient preferences. Early intervention can improve quality of life and communication abilities.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H80.93 a billable ICD-10 code?
Yes, H80.93 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H80.93?
Clinical documentation must specify the nature of Unspecified otosclerosis, bilateral and any associated comorbidities for accurate reporting.

Cite this Clinical Reference